# Evaluation of Efficacy and Safety of Insulin Glargine Injected by Needle-free Jet Syringe

> **NCT04093284** · NA · UNKNOWN · sponsor: **Nanjing First Hospital, Nanjing Medical University** · enrollment: 60 (estimated)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DEVICE:** The needle-free jet injector

## Key facts

- **NCT ID:** NCT04093284
- **Lead sponsor:** Nanjing First Hospital, Nanjing Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-09-12
- **Primary completion:** 2019-10-20
- **Final completion:** 2019-10-30
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2019-09-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04093284

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04093284, "Evaluation of Efficacy and Safety of Insulin Glargine Injected by Needle-free Jet Syringe". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04093284. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*